Profile
Avery W.
Catlin is currently the Director at Corbus Pharmaceuticals, Inc. and the Vice President at CuraGen Corp.
Previously, he served as the Independent Director at Provention Bio, Inc. from 2018 to 2023 and at Corbus Pharmaceuticals Holdings, Inc. from 2014 to 2024.
He also held the position of Chief Financial Officer at MediSense, Inc. and Repligen Corp.
from 1992 to 1996 and Chief Financial Officer & VP-Operations at Endogen, Inc. from 1996 to 1999.
From 2000 to 2008, he was the Chief Financial Officer, Secretary & SVP at AVANT Immunotherapeutics, Inc. and from 2011 to 2017, he served as the CFO, Secretary, Treasurer & Senior Vice President at Celldex Therapeutics, Inc. Mr. Catlin completed his undergraduate degree at the University of Virginia and holds an MBA from Babson College.
Avery Catlin active positions
| Companies | Position | Start |
|---|---|---|
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Corporate Officer/Principal | - |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Director/Board Member | - |
Former positions of Avery Catlin
| Companies | Position | End |
|---|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Director/Board Member | 15/08/2024 |
| PROVENTION BIO, INC. | Director/Board Member | 27/04/2023 |
| CELLDEX THERAPEUTICS, INC. | Director of Finance/CFO | 30/06/2017 |
AVANT Immunotherapeutics, Inc.
AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes vaccines and therapeutics | Director of Finance/CFO | 01/10/2008 |
Endogen, Inc.
Endogen, Inc. Medical SpecialtiesHealth Technology Makes reagents & immuno-assay test kits | Director of Finance/CFO | 01/01/1999 |
Training of Avery Catlin
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
MediSense, Inc.
MediSense, Inc. Medical SpecialtiesHealth Technology Provides blood-glucose monitoring systems | Health Technology |
Repligen Corp.
Repligen Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures biologic drugs | Health Technology |
Endogen, Inc.
Endogen, Inc. Medical SpecialtiesHealth Technology Makes reagents & immuno-assay test kits | Health Technology |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Health Technology |
AVANT Immunotherapeutics, Inc.
AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes vaccines and therapeutics | Health Technology |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Babson College
Babson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celldex Therapeutics, Inc.
Celldex Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes immunotherapy technologies for the treatment of cancer and other diseases | Health Technology |
Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases | Health Technology |
Provention Bio, Inc.
Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company that engages in intercepting and preventing immune-mediated diseases including type 1 diabetic activities | Health Technology |
- Stock Market
- Insiders
- Avery Catlin
















